Research details how a virus hijacks cell signals to cause infectionJanuary 13, 2006A common virus that causes meningitis and heart inflammation takes a "back door" approach to evade natural barriers, then exploits biological signals to infect human cells. Broadening knowledge of how viruses cause infection, a new study describes elaborate methods that the virus has evolved to bypass the body's defenses. "This study helps to explain how group B coxsackieviruses infect cells," said Jeffrey M. Bergelson, M.D., a pediatric infectious diseases specialist at The Children's Hospital of Philadelphia. "We found new steps in the virus life cycle." Dr. Bergelson's study, co-authored with Carolyn B. Coyne, Ph.D., also of Children's Hospital, appears in the Jan. 13 issue of the journal Cell. Group B coxsackieviruses (CVBs) are common in people, but usually are defeated by the immune system after causing minor infections. However, CVBs may sometimes cause myocarditis, a potentially severe inflammation of the heart in children and adults, as well as viral meningitis, which inflames the lining of the brain. Rarely, the virus may lead to fatal, overwhelming infection in newborns. CVBs typically reach people in contaminated food or water, with the virus entering cells that line the intestine, called epithelial cells. Just how the virus enters those cells has been puzzling to scientists. Dr. Bergelson previously discovered a cell receptor called the coxsackievirus and adenovirus receptor (CAR) to which the virus attaches itself. However, the CAR remains below the surface of epithelial cells, in a seemingly inaccessible location called the tight junction. In the new study, Drs. Bergelson and Coyne found that CVBs have evolved an indirect route of attack. The virus first attaches itself to more accessible cell receptors called DAF receptors that lie exposed on the upper surface of epithelial cells. After attaching itself to a DAF receptor, the virus triggers two signals that open the door to infection. One signal causes the virus to move into the tight junction, where it can reach the CAR. A second signal leads the virus to move deeper into cells where it can release its nucleic acid payload and complete the process of infection. "We showed for the first time that this virus is dependent on signaling pathways to drive invasion," said Dr. Bergelson. Specifically, the coxsackievirus activates kinases, enzymes that are instrumental in moving structures within cells. "These particular kinases were previously known to be active in cancers, where their signaling functions go out of control," he added. "However, kinases have a normal function, in enabling cells to respond to hormones or growth factors. We showed in this study that viruses can co-opt kinase signaling processes to advance an infection." In describing how the coxsackievirus takes advantage of signaling pathways, added Dr. Bergelson, his investigations revealed steps in a virus's life cycle that were previously unknown. "Eventually this understanding may yield clinical benefits, by contributing to future therapies to block viral infections. For now, we have learned more about cell functions, and how viruses may evolve unexpected methods to force themselves into cells." Children's Hospital of Philadelphia |
|||||||||||||||||||||
| Related Virus Current Events and Virus News Articles Amid the flu epidemic, don't forget RSV in young children Influenza, particularly H1N1, has understandably captured the attention of public health officials, the media and the public. On the Trail of a Vaccine for Lyme Disease: Yale Researchers Target Tick Saliva A protein found in the saliva of ticks helps protect mice from developing Lyme disease, Yale researchers have discovered. The findings, published in the November 19 issue of Cell Host & Microbe, may spur development of a new vaccine against infection from Lyme disease, which is spread through tick bites. An atomic-level look at an HIV accomplice Since the discovery in 2007 that a component of human semen called SEVI boosts infectivity of the virus that causes AIDS, researchers have been trying to learn more about SEVI and how it works, in hopes of thwarting its infection-promoting activity. Preventing H1N1 spread to health care workers: Dilemma, debate and confusion A commentary in the December issue of The Lancet Infectious Diseases brings to light the gaps in knowledge on the transmission of a common pathogen - the influenza virus - and its impact on decisions about how best to protect health care workers. New findings suggest strategy to help generate HIV-neutralizing antibodies New discoveries about anti-HIV antibodies may bring researchers a step closer to creating an effective HIV vaccine, according to a new paper co-authored by scientists at the Vaccine Research Center of the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health. UAB Researchers Discover Antibody Receptor Identity, Propose Renaming Immune-System Gene Researchers at the University of Alabama at Birmingham (UAB) have uncovered the genetic identity of a cellular receptor for the immune system's first-response antibody, a discovery that sheds new light on infection control and immune disorders. New culprit for viral infections among elderly -- an overactive immune response Researchers at Yale School of Medicine have found that exaggerated responses of the immune system explain why the elderly succumb to viral infections more readily than younger people. The Protein Srebp2 Drives Cholesterol Formation in Prion-Infected Neuronal Cells Which May Promote Prion-Dependent Diseases The regulating protein Srebp2 drives cholesterol formation, which prions need for their propagation, in prion-infected neuronal cells. New research helps explain why bird flu has not caused a pandemic Bird flu viruses would have to make at least two simultaneous genetic mutations before they could be transmitted readily from human to human, according to research published today in PLoS ONE. Toward explaining why hepatitis B hits men harder than women Scientists in China are reporting discovery of unusual liver proteins, found only in males, that may help explain the long-standing mystery of why the hepatitis B virus (HBV) sexually discriminates -- hitting men harder than women. More Virus Current Events and Virus News Articles |
|||||||||||||||||||||
|
|||||||||||||||||||||
|
|||||||||||||||||||||